David Robinson

Summary

Country: Sweden

Publications

  1. pmc Use of 5α-reductase inhibitors for lower urinary tract symptoms and risk of prostate cancer in Swedish men: nationwide, population based case-control study
    David Robinson
    Department of Surgery and Perioperative Sciences, Umea University, 901 85 Umea, Sweden
    BMJ 346:f3406. 2013
  2. ncbi request reprint Long-term follow-up of conservatively managed incidental carcinoma of the prostate: a multivariate analysis of prognostic factors
    David Robinson
    Section of Urology, Ryhov County Hospital, Jonkoping, Sweden
    Scand J Urol Nephrol 41:103-9. 2007
  3. doi request reprint Ischemic heart disease and stroke before and during endocrine treatment for prostate cancer in PCBaSe Sweden
    David Robinson
    Department of Surgical and Perioperative Sciences, Urology and Andrology, Umea University, Sweden
    Int J Cancer 130:478-87. 2012
  4. doi request reprint PSA kinetics provide improved prediction of survival in metastatic hormone-refractory prostate cancer
    David Robinson
    Department of Urology, Ryhov County Hospital, Jonkoping, Sweden
    Urology 72:903-7. 2008
  5. pmc Outcomes in localized prostate cancer: National Prostate Cancer Register of Sweden follow-up study
    Par Stattin
    Urology and Andrology, Department of Surgical and Perioperative Science, Umea University Hospital, Umea, Sweden
    J Natl Cancer Inst 102:950-8. 2010
  6. ncbi request reprint Prediction of survival of metastatic prostate cancer based on early serial measurements of prostate specific antigen and alkaline phosphatase
    David Robinson
    Department of Urology, Ryhov County Hospital, Jonkoping, Sweden
    J Urol 179:117-22; discussion 122-3. 2008
  7. ncbi request reprint Prognostic factors and survival in node-positive (N1) prostate cancer-a prospective study based on data from a Swedish population-based cohort
    Gunnar Aus
    Department of Urology, Sahlgrens University Hospital, 413 45, Goteborg, Sweden
    Eur Urol 43:627-31. 2003
  8. ncbi request reprint Survival in prostate carcinoma--outcomes from a prospective, population-based cohort of 8887 men with up to 15 years of follow-up: results from three countries in the population-based National Prostate Cancer Registry of Sweden
    Gunnar Aus
    Department of Urology, Sahlgrens University Hospital, Goteborg, Sweden
    Cancer 103:943-51. 2005
  9. ncbi request reprint First impressions in complementary practice: the importance of environment, dress and address to the therapeutic relationship
    Roger Newman Turner
    Research Council for Complementary Medicine, UK
    Complement Ther Clin Pract 13:102-9. 2007

Detail Information

Publications9

  1. pmc Use of 5α-reductase inhibitors for lower urinary tract symptoms and risk of prostate cancer in Swedish men: nationwide, population based case-control study
    David Robinson
    Department of Surgery and Perioperative Sciences, Umea University, 901 85 Umea, Sweden
    BMJ 346:f3406. 2013
    ..To assess the association between 5α-reductase inhibitor (5-ARI) use in men with lower urinary tract symptoms and prostate cancer risk...
  2. ncbi request reprint Long-term follow-up of conservatively managed incidental carcinoma of the prostate: a multivariate analysis of prognostic factors
    David Robinson
    Section of Urology, Ryhov County Hospital, Jonkoping, Sweden
    Scand J Urol Nephrol 41:103-9. 2007
    ..To evaluate the disease-specific mortality of conservatively managed incidental carcinoma of the prostate (T1a and T1b) in relation to prognostic factors...
  3. doi request reprint Ischemic heart disease and stroke before and during endocrine treatment for prostate cancer in PCBaSe Sweden
    David Robinson
    Department of Surgical and Perioperative Sciences, Urology and Andrology, Umea University, Sweden
    Int J Cancer 130:478-87. 2012
    ..Our data underline the importance of a proper indication for ET because many men with low-risk prostate cancer currently receive ET...
  4. doi request reprint PSA kinetics provide improved prediction of survival in metastatic hormone-refractory prostate cancer
    David Robinson
    Department of Urology, Ryhov County Hospital, Jonkoping, Sweden
    Urology 72:903-7. 2008
    ..To assess the value of prostate-specific antigen (PSA) kinetics in predicting survival and relate this to the baseline variables in men with metastatic hormone-refractory prostate cancer (HRPC)...
  5. pmc Outcomes in localized prostate cancer: National Prostate Cancer Register of Sweden follow-up study
    Par Stattin
    Urology and Andrology, Department of Surgical and Perioperative Science, Umea University Hospital, Umea, Sweden
    J Natl Cancer Inst 102:950-8. 2010
    ..To our knowledge, there are no outcome studies from contemporary population-based cohorts that include data on stage, Gleason score, and serum levels of prostate-specific antigen (PSA)...
  6. ncbi request reprint Prediction of survival of metastatic prostate cancer based on early serial measurements of prostate specific antigen and alkaline phosphatase
    David Robinson
    Department of Urology, Ryhov County Hospital, Jonkoping, Sweden
    J Urol 179:117-22; discussion 122-3. 2008
    ..We determined how serial measurements of prostate specific antigen and alkaline phosphatase can be used to predict survival early in the course of hormone treated metastatic prostate cancer...
  7. ncbi request reprint Prognostic factors and survival in node-positive (N1) prostate cancer-a prospective study based on data from a Swedish population-based cohort
    Gunnar Aus
    Department of Urology, Sahlgrens University Hospital, 413 45, Goteborg, Sweden
    Eur Urol 43:627-31. 2003
    ..It is difficult to give prognostic information based on the present literature. The aim of this study was to evaluate the impact of known risk factors in patients with pelvic node involvement and without distant metastasis...
  8. ncbi request reprint Survival in prostate carcinoma--outcomes from a prospective, population-based cohort of 8887 men with up to 15 years of follow-up: results from three countries in the population-based National Prostate Cancer Registry of Sweden
    Gunnar Aus
    Department of Urology, Sahlgrens University Hospital, Goteborg, Sweden
    Cancer 103:943-51. 2005
    ..To decide on screening strategies and curative treatments for prostate carcinoma, it is necessary to determine the incidence and survival in a population that is not screened...
  9. ncbi request reprint First impressions in complementary practice: the importance of environment, dress and address to the therapeutic relationship
    Roger Newman Turner
    Research Council for Complementary Medicine, UK
    Complement Ther Clin Pract 13:102-9. 2007
    ..It was not influenced by gender or treatment modality. Further research is recommended in order to understand how the complex verbal and non-verbal communication implicit in the CAM setting may affect the therapeutic relationship...